Abstract
The broad literature linking psoriasis to metabolic disorders has led to changes in standard of care recommendations for patients with psoriasis. In particular, practitioners are encouraged to screen psoriasis patients, especially when disease is severe, for metabolic disorders and cardiovascular risk factors and institute appropriate prevention strategies. Additional studies investigating the role of psoriasis activity and severity as an independent risk factor for developing metabolic disorders, atherosclerosis, and myocardial infarction and the role of psoriasis treatment in altering the risk of developing these serious morbidities are urgently needed.
| Original language | English |
|---|---|
| Pages (from-to) | 416-422 |
| Number of pages | 7 |
| Journal | Current Opinion in Rheumatology |
| Volume | 20 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2008 |
| Externally published | Yes |
Keywords
- Epidemiology
- Inflammation
- Metabolic syndrome
- Myocardial infarction
- Psoriasis